PARP1 and Alzheimer disease: In addition, it has been proposed that activated PARP-1 in patients with AD can block mitochondrial respiration and impair mitochondrial function by lowering the expression of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α).